- Telegram：@dzsms777
- WhatsApp：+1(305)6290111
Latest Updates
Preventing Chinese companies from quickly plagiarizing Ameri
Over the past few decades, start-up biotech companies in the United States have publicly released their early research findings to attract investment. But now, in order to prevent competitors, especially Chinese biopharmaceutical companies, from quickly copying and conducting human trials in advance, more and more American pharmaceutical companies are choosing to keep a low profile and highly confidential their early research results.
According to a report by The Wall Street Journal, whenever American pharmaceutical companies present successful clinical trials at major medical conferences, Chinese biopharmaceutical companies quickly copy and use the same biotechnology to quickly conduct clinical trials.
In many cases, Chinese biopharmaceutical companies conduct research at twice the speed of the United States, but at only half the cost, posing a huge threat to the US pharmaceutical industry. Forcing American pharmaceutical companies, regardless of their size, to think twice before disclosing their latest biopharmaceutical technologies.
-
Preventing Chinese companies from quickly plagiarizing Ameri 2026-07-11 - Dilraba trains hard to gain weight for 'Women's Football' wi 2026-07-11
- The UK government plans to increase research investment, wit 2026-07-10
- The federal deficit for the first nine months of the 2026 fi 2026-07-10
- Iran says Strait of Hormuz passage capacity has been restore 2026-07-10
Related Product
Related News
- 1600 Pennsylvania Ave NW,Washington,DC20500,USA
- Telegram: @dzsms777
- Tg Group: @dzsms777
- WhatsApp: +1(305)6290111
Contact Us
Telegram: @dzsms777
WhatsApp: +1(305)6290111
WhatsApp: +1(305)6290111
Sms Broadcaster Machine Telegram：@dzsms777